Skip to search formSkip to main contentSkip to account menu

CGP 74588

Known as: CGP-74588, CGP74588 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Objective: The tyrosine kinase inhibitors (TKIs) used in the treatment of chronic myeloid leukemia are substrates for the efflux… 
2013
2013
...................................................................................................................... 5 POPUL… 
2013
2013
We thank Chatelut and colleagues for their interest in our prospective population pharmacokinetic analysis of imatinib exposure… 
2012
2012
1115 2012 52 1115-1120 I (STI571, Gleevec) was the first approved rationally designed inhibitor of tyrosine kinases and is… 
Highly Cited
2008
Highly Cited
2008
Background: Imatinib mesylate is used in combination with hydroxyurea (HU) in ongoing clinical phase II studies in recurrent… 
2008
2008
2526 Background: The aim of this study was to explore the impact of several demographic, biological and pharmacogenetic…